- Previous Close
58.20 - Open
59.90 - Bid 58.13 x --
- Ask 58.17 x --
- Day's Range
57.80 - 58.64 - 52 Week Range
57.25 - 97.20 - Volume
4,324,114 - Avg. Volume
3,480,130 - Market Cap (intraday)
45.658B - Beta (5Y Monthly) -0.42
- PE Ratio (TTM)
24.73 - EPS (TTM)
2.35 - Earnings Date --
- Forward Dividend & Yield 1.00 (1.72%)
- Ex-Dividend Date May 15, 2024
- 1y Target Est
84.07
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
www.snibe.comRecent News: 300832.SZ
View MorePerformance Overview: 300832.SZ
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300832.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300832.SZ
View MoreValuation Measures
Market Cap
45.66B
Enterprise Value
43.08B
Trailing P/E
24.67
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.29
Price/Book (mrq)
5.62
Enterprise Value/Revenue
9.71
Enterprise Value/EBITDA
20.40
Financial Highlights
Profitability and Income Statement
Profit Margin
41.72%
Return on Assets (ttm)
14.87%
Return on Equity (ttm)
24.32%
Revenue (ttm)
4.44B
Net Income Avi to Common (ttm)
1.85B
Diluted EPS (ttm)
2.35
Balance Sheet and Cash Flow
Total Cash (mrq)
2.59B
Total Debt/Equity (mrq)
0.06%
Levered Free Cash Flow (ttm)
967.3M